Tech Company Financing Transactions
Sophia Genetics Funding Round
Sophia Genetics, based in Saint Sulpice, secured $77 million from Generation Investment Management, Alychlo NV and Balderton Capital.
Transaction Overview
Company Name
Announced On
1/7/2019
Transaction Type
Venture Equity
Amount
$77,000,000
Round
Series E
Investors
Proceeds Purpose
Sophia said that it will apply much of the new funding to expand its US presence by growing its workforce and marketing to more American hospitals.
Company Information
Company Status
Publicly-held
Industry
Healthcare IT
Mailing Address
Rue du Centre 172
Saint Sulpice, CH-1025
Switzerland
Saint Sulpice, CH-1025
Switzerland
Phone
Website
Email Address
Overview
We at SOPHiA GENETICS want to contribute to make the global healthcare system more sustainable. It is our strong belief that digital technologies are the key to unlocking the era of Data-Driven Medicine, where secure data pooling and knowledge sharing will be extremely valuable for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jurgi Camblong
Chief Financial Officer
Valentin Matillon
Chief Information Officer
Adam Molyneaux
Chief Technical Officer
Zhenyu Xu
General Manager
Kevin Puylaert
Vice President
Gioia Althoff
Vice President
Thierry Colin
Vice President
Esteban Czwan
Vice President
Didier Pitton
VP - Bus. Development
Damien Lapray
Browse more venture capital transactions:
Prev: 1/7/2019: Pear Therapeutics venture capital transaction
Next: 1/7/2019: Dashbot venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs